Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 4,991
Out of 4,996 analysts
16
Total ratings
8.33%
Success rate
-41.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI Atai Life Sciences | Initiates: Buy | $18 | $5.27 | +241.56% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $21.05 | -19.24% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $5.80 | +486.21% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $116.76 | -18.64% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $1.89 | +5.82% | 2 | May 20, 2022 | |
| ATHA Athira Pharma | Initiates: Buy | $330 | $3.86 | +8,449.22% | 1 | Apr 21, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $1.44 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $5.07 | +531.16% | 4 | Dec 16, 2020 |
Atai Life Sciences
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $5.27
Upside: +241.56%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $21.05
Upside: -19.24%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $5.80
Upside: +486.21%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $116.76
Upside: -18.64%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $1.89
Upside: +5.82%
Athira Pharma
Apr 21, 2022
Initiates: Buy
Price Target: $330
Current: $3.86
Upside: +8,449.22%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $1.44
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $5.07
Upside: +531.16%